Medico Intercontinental consolidated net profit rises 52.63% in the March 2022 quarter

Medico Intercontinental consolidated net profit rises 8.82% in the September 2021 quarter

Hasn't fared well - amongst the low performers

Can be considered moderately valued vs the market

Lagging behind the market in financials growth

Showing good signs of profitability & efficiency

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Good time to consider, stock is not in the overbought zone

Medico Intercontinental Ltd is engaged in the trading of pharmaceutical products